Sanara MedTech Inc. (SMTI) Tops Q1 EPS by 8c

Sanara MedTech Inc. (NASDAQ: SMTI) reported Q1 EPS of $0.04, $0.08 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $27.8 million versus the consensus estimate of $26.9 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.

You May Also Be Interested In

• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
• Agora Inc. (API) PT Raised to $6.80 at BofA Securities